277 related articles for article (PubMed ID: 20179431)
1. State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop.
Barnhill RL; Cerroni L; Cook M; Elder DE; Kerl H; LeBoit PE; McCarthy SW; Mihm MC; Mooi WJ; Piepkorn MW; Prieto VG; Scolyer RA
Adv Anat Pathol; 2010 Mar; 17(2):73-90. PubMed ID: 20179431
[TBL] [Abstract][Full Text] [Related]
2. Dysplastic changes in different types of melanocytic nevi. A unifying concept.
Toussaint S; Kamino H
J Cutan Pathol; 1999 Feb; 26(2):84-90. PubMed ID: 10082398
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
Barnhill RL
Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
[TBL] [Abstract][Full Text] [Related]
4. Nevic mitoses: a review of 1041 cases.
O'Rourke EA; Balzer B; Barry CI; Frishberg DP
Am J Dermatopathol; 2013 Feb; 35(1):30-3. PubMed ID: 22688393
[TBL] [Abstract][Full Text] [Related]
5. Dysplastic melanocytic nevi and prognostically indeterminate nevomelanomatoid proliferations.
Kim JC; Murphy GF
Clin Lab Med; 2000 Dec; 20(4):691-712. PubMed ID: 11221510
[TBL] [Abstract][Full Text] [Related]
6. Atypical melanocytic lesions of the thigh with spitzoid and dysplastic features: a clinicopathologic study of 29 cases.
Buonaccorsi JN; Lynott J; Plaza JA
Ann Diagn Pathol; 2013 Jun; 17(3):265-9. PubMed ID: 23312707
[TBL] [Abstract][Full Text] [Related]
7. Dermatopathology updates on melanocytic lesions.
Cheung WL; Smoller BR
Dermatol Clin; 2012 Oct; 30(4):617-22, vi. PubMed ID: 23021049
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
9. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi).
Ko CJ; McNiff JM; Glusac EJ
J Cutan Pathol; 2009 Oct; 36(10):1063-8. PubMed ID: 19187111
[TBL] [Abstract][Full Text] [Related]
10. Melanocytic nevi simulant of melanoma with medicolegal relevance.
Massi G
Virchows Arch; 2007 Sep; 451(3):623-47. PubMed ID: 17653760
[TBL] [Abstract][Full Text] [Related]
11. The role of lymphatic mapping and sentinel node biopsy in the management of atypical and anomalous melanocytic lesions.
Cochran AJ; Binder S; Morton DL
J Cutan Pathol; 2010 Apr; 37 Suppl 1():54-9. PubMed ID: 20482676
[TBL] [Abstract][Full Text] [Related]
12. Blue nevi and related tumors.
Phadke PA; Zembowicz A
Clin Lab Med; 2011 Jun; 31(2):345-58. PubMed ID: 21549247
[TBL] [Abstract][Full Text] [Related]
13. Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls.
Murali R; McCarthy SW; Scolyer RA
Adv Anat Pathol; 2009 Nov; 16(6):365-82. PubMed ID: 19851128
[TBL] [Abstract][Full Text] [Related]
14. Pigmented lesions in children: when to worry.
Schaffer JV
Curr Opin Pediatr; 2007 Aug; 19(4):430-40. PubMed ID: 17630608
[TBL] [Abstract][Full Text] [Related]
15. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
16. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
17. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").
Barnhill RL; Argenyi Z; Berwick M; Duray PH; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Paine S; Piepkorn MW; Prieto V; Rabkin MS; Schmidt B; Selim A; Shea CR; Trotter MJ
Am J Surg Pathol; 2008 Jan; 32(1):36-44. PubMed ID: 18162768
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotype and possible origin of nevi with phenotypical heterogeneity.
Winnepenninckx V; van den Oord JJ
Arch Dermatol Res; 2004 Jul; 296(2):49-53. PubMed ID: 15141316
[TBL] [Abstract][Full Text] [Related]
19. The dermal-based borderline melanocytic tumor: a categorical approach.
Magro CM; Crowson AN; Mihm MC; Gupta K; Walker MJ; Solomon G
J Am Acad Dermatol; 2010 Mar; 62(3):469-79. PubMed ID: 20159313
[TBL] [Abstract][Full Text] [Related]
20. Melanocytic "ball-in-mitts" and "microalveolar structures" and their role in the development of cellular blue nevi.
Kazakov DV; Michal M
Ann Diagn Pathol; 2007 Jun; 11(3):160-75. PubMed ID: 17498590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
